Cardinal Health Acquisition-related cash and share-based compensation costs increased by 67.2% to $112.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 460.0%, from $20.00M to $112.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels suggest aggressive M&A integration or retention efforts, which may be necessary for deal success but increase short-term expenses.
This represents cash payments and equity-based compensation specifically tied to acquisition agreements, such as retenti...
Specific to companies with frequent M&A; often categorized under acquisition-related adjustments.
other_acquisition_related_cash_and_share_based_compensat_c19819| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $131.00M | $20.00M | $106.00M | $64.00M | $67.00M | $112.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | -84.7% | +430.0% | -39.6% | +4.7% | +67.2% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | — | -48.9% | +460.0% |